| Literature DB >> 33778978 |
Helena Sousa1, Roberta Frontini2,3, Oscar Ribeiro4, Constança Paúl5, Elísio Costa6, Leonilde Amado7, Vasco Miranda7, Fernando Ribeiro8, Daniela Figueiredo1.
Abstract
INTRODUCTION: Caring for a patient with end-stage renal disease undergoing in-centre haemodialysis can be a stressful experience, likely to involve significant burden. Within the context of the new coronavirus pandemic, these patients are highly vulnerable to infection by COVID-19, which might increase the care demands and burden of family caregivers. AIM: This study aimed to explore the subjective experiences of family caregivers of non-COVID-19 patients with end-stage renal disease undergoing in-centre haemodialysis during the COVID-19 lockdown. STUDYEntities:
Keywords: COVID-19; coronavirus; end-stage renal disease; family caregivers; haemodialysis; qualitative study
Mesh:
Year: 2021 PMID: 33778978 PMCID: PMC8251279 DOI: 10.1111/scs.12980
Source DB: PubMed Journal: Scand J Caring Sci ISSN: 0283-9318
Sociodemographic, caregiving and clinical characteristics of the 19 family caregivers, and sociodemographic and clinical information of the cared‐for persons with ESRD.
| Sociodemographic, caregiving and clinical information | Family caregivers ( |
|---|---|
| Gender | |
| Female, | 17 (89.5) |
| Male, | 2 (10.5) |
| Age (years old), | 50.7 ± 14.0 [22–81] |
| Education, | |
| Basic education | 3 (15.8) |
| Middle school | 8 (42.1) |
| Secondary education | 5 (26.3) |
| Higher education | 3 (15.8) |
| Marital status, | |
| Married | 15 (78.9) |
| Single | 4 (21.1) |
| Family relationship, | |
| Spouse – partner | 7 (36.8) |
| Child (caregiver) | 11 (57.9) |
| Sister | 1 (5.3) |
| How long have you been providing support to your family member with ESRD? | |
| Less than 1 year | 1 (5.3) |
| Between 1 and 2 years | 6 (31.6) |
| Between 2 and 4 years | 8 (42.1) |
| Over 4 years | 4 (21.1) |
| Risk perception of the person with ESRD to be infected by COVID−19, | |
| Low risk | 1 (5.3) |
| Moderate risk | 1 (5.3) |
| High risk | 15 (78.9) |
| Rather not answer | 2 (10.5) |
| Decreased mental health status due to COVID−19, | |
| Yes | 12 (63.2) |
| No | 7 (36.8) |
| Decreased sleep quality due to COVID−19, | |
| Yes | 12 (63.2) |
| No | 7 (36.8) |
Themes, subthemes and number of appearances of each subtheme across the family caregivers’ narratives (n = 19).
| Major themes | Subthemes | Number of appearances |
|---|---|---|
| Emotional distress | Fear of being contaminated with COVID−19 and contaminating the relative with ESRD | 15 |
| Fear that the cared‐for person with ESRD gets contaminated when going to haemodialysis | 15 | |
| Fear that the family member with ESRD dies due to COVID−19 | 10 | |
| Concerns about the future | 7 | |
| Changes in caregiving tasks | Increased number of caregiving responsibilities | 13 |
| Decreased family interactions and help in the performance of care activities | 12 | |
| Educational and supportive needs | Need for more information, better communication and support from the dialysis team | 9 |
| Coping strategies | Adherence to the prevention and protection measures | 17 |
| What has changed in your life after the declaration of the state of emergency and all the measures regarding the new coronavirus? |
| How has this pandemic affected you? And your family member with ESRD? |
| What have you done to deal with the current situation? |
| What has been the most difficult? How have you dealt with this? What do you do to overcome these difficulties? |
| What has been easier and why? What could facilitate your family member's disease management in the context of the COVID−19 pandemic and lockdown? |
| Do you currently need some support? What are your main needs in the context of the pandemic and lockdown? And what are the needs of your family member with ESRD? |
| What are your concerns or fears about the coronavirus and ESRD? What about the haemodialysis treatment? What about you, as a family caregiver? What do you fear the most? |
| Topic | Item No. | Guide Questions/Description | Page |
|---|---|---|---|
| Domain 1: Research team and reflexivity | |||
| Personal characteristics | |||
| Interviewer/facilitator | 1 | Which author/s conducted the interview or focus group? | 5 |
| Credentials | 2 |
What were the researcher's credentials? E.g. PhD, MD
| NR |
| Occupation | 3 |
What was their occupation at the time of the study?
| NR |
| Gender | 4 |
Was the researcher male or female?
| NR |
| Experience and training | 5 |
What experience or training did the researcher have?
| NR |
| Relationship with participants | |||
| Relationship established | 6 | Was a relationship established prior to study commencement? | No |
| Participant knowledge of the interviewer | 7 |
What did the participants know about the researcher? e.g. personal goals, reasons for doing the research
| NR |
| Interviewer characteristics | 8 |
What characteristics were reported about the inter viewer/facilitator? e.g. Bias, assumptions, reasons and interests in the research topic
| NR |
| Domain 2: Study design | |||
| Theoretical framework | |||
| Methodological orientation and Theory | 9 | What methodological orientation was stated to underpin the study? e.g. grounded theory, discourse analysis, ethnography, phenomenology, content analysis | 4 |
| Participant selection | |||
| Sampling | 10 | How were participants selected? e.g. purposive, convenience, consecutive, snowball | 4 |
| Method of approach | 11 | How were participants approached? e.g. face‐to‐face, telephone, mail, email | 4 |
| Sample size | 12 | How many participants were in the study? | 4 |
| Non‐participation | 13 | How many people refused to participate or dropped out? Reasons? | 4 |
| Setting | |||
| Setting of data collection | 14 | Where was the data collected? e.g. home, clinic, workplace | 5 |
| Presence of non‐participants | 15 | Was anyone else present besides the participants and researchers? | 5 |
| Description of sample | 16 | What are the important characteristics of the sample? e.g. demographic data, date | Table |
| Data collection | |||
| Interview guide | 17 | Were questions, prompts, guides provided by the authors? Was it pilot tested? | Appendix |
| Repeat interviews | 18 | Were repeat interviews carried out? If yes, how many? | No |
| Audio/visual recording | 19 | Did the research use audio or visual recording to collect the data? | 5 |
| Field notes | 20 | Were field notes made during and/or after the interview or focus group? | 5 |
| Duration | 21 | What was the duration of the interviews or focus group? | 5 |
| Data saturation | 22 | Was data saturation discussed? | No |
| Transcripts returned | 23 | Were transcripts returned to participants for comment and/or correction? | No |
| Domain 3: analysis and findings | |||
| Data analysis | |||
| Number of data coders | 24 | How many data coders coded the data? | 5 |
| Description of the coding tree | 25 | Did authors provide a description of the coding tree? | No |
| Derivation of themes | 26 | Were themes identified in advance or derived from the data? | 5–6 |
| Software | 27 | What software, if applicable, was used to manage the data? | NA |
| Participant checking | 28 | Did participants provide feedback on the findings? | No |
| Reporting | |||
| Quotations presented | 29 | Were participant quotations presented to illustrate the themes/findings? Was each quotation identified? E.g. participant number | 7–12 |
| Data and findings consistent | 30 | Was there consistency between the data presented and the findings? | 7–12 |
| Clarity of major themes | 31 | Were major themes clearly presented in the findings? | 7–12 |
| Clarity of minor themes | 32 | Is there a description of diverse cases or discussion of minor themes? | 13–15 |